Financial Results (Standalone)

Half Year Ended September 30, 2026 (Unaudited)

  • Total Revenue: ₹9173.18 lakh
  • Net Sales/Income From Operations: ₹9113.23 lakh
  • Other Operating Income: ₹59.95 lakh
  • Total Expenses: ₹8794.60 lakh
  • Cost of material consumed: ₹8551.25 lakh
  • Purchase of Stock-in-trade: ₹138.26 lakh
  • Changes in inventory: -₹448.59 lakh
  • Employee benefits expenses: ₹42.58 lakh
  • Finance costs: ₹45.21 lakh
  • Depreciation expense: ₹27.88 lakh
  • Other expenses: ₹438.01 lakh
  • Profit Before Tax: ₹378.58 lakh
  • Tax Expense: ₹88.97 lakh
  • Current year tax: ₹87.92 lakh
  • Prior years tax: ₹1.05 lakh
  • Net Profit for Period: ₹289.61 lakh
  • Earnings Per Share (₹5 face value): ₹1.49 (Basic and Diluted)
  • Paid-up Equity Share Capital: ₹971.25 lakh
  • Reserves Excluding Revaluation Reserve: ₹3386.0 lakh (as at March 31, 2026)

Comparative Figures

  • Half Year Ended March 31, 2026: Net Profit ₹349.89 lakh, Revenue ₹10512.44 lakh, EPS ₹2.43
  • Half Year Ended September 30, 2025: Net Profit ₹227.09 lakh, Revenue ₹7218.79 lakh, EPS ₹1.58
  • Year Ended March 31, 2026: Net Profit ₹576.98 lakh, Revenue ₹17731.24 lakh, EPS ₹4.0

Assets and Liabilities (Standalone)

As at September 30, 2026 (Unaudited)

  • Total Equity and Liabilities: ₹5872.53 lakh
  • Shareholder's funds: ₹4646.94 lakh
  • Share capital: ₹971.25 lakh
  • Reserves and surplus: ₹3675.69 lakh
  • Non-current liabilities: ₹144.04 lakh
  • Long-term borrowings: ₹83.85 lakh
  • Deferred tax liabilities: ₹51.26 lakh
  • Long-term provisions: ₹8.93 lakh
  • Current liabilities: ₹1081.55 lakh
  • Short-term borrowings: ₹890.10 lakh
  • Trade payables: ₹50.89 lakh
  • Other current liabilities: ₹87.92 lakh
  • Short-term provisions: ₹42.60 lakh
  • Total Assets: ₹5872.53 lakh
  • Non-current assets: ₹1097.49 lakh
  • Property, Plant and Equipment: ₹1041.69 lakh
  • Other non-current assets: ₹55.80 lakh
  • Current assets: ₹4775.04 lakh
  • Inventories: ₹3770.37 lakh
  • Trade receivables: ₹678.37 lakh
  • Cash and cash equivalents: ₹148.62 lakh
  • Other current assets: ₹177.68 lakh

Comparative Figures (March 31, 2026)

  • Total Equity and Liabilities: ₹5234.95 lakh
  • Total Assets: ₹5234.95 lakh

Cash Flow Statement (Standalone)

Half Year Ended September 30, 2026 (Unaudited)

  • Net Cash flow from Operating Activities: -₹1014.79 lakh
  • Net Cash used in Investing Activities: -₹4.00 lakh
  • Net Cash used in Financing Activities: ₹406.4 lakh

Year Ended March 31, 2026 (Audited)

  • Net Cash flow from Operating Activities: ₹1466.45 lakh
  • Net Cash used in Investing Activities: -₹68.44 lakh
  • Net Cash used in Financing Activities: -₹662.50 lakh
  • Net Increase in Cash & Cash Equivalents: ₹735.11 lakh

IPO Funds Utilization

Original Allocation (₹2502.75 lakh)

  • Working Capital: ₹1932.61 lakh
  • Issue related expenses: ₹220.14 lakh
  • General Corporate Purposes: ₹350.00 lakh

Utilization as at September 30, 2026

  • Total Utilized: ₹2387.75 lakh (95.4% of proceeds)
  • Working Capital: ₹1932.61 lakh (100% of allocation)
  • Issue related expenses: ₹105.14 lakh
  • General Corporate Purposes: ₹350.00 lakh (100% of allocation)
  • Unutilized Amount: ₹115.00 lakh (from issue expenses allocation)

Important Note on Unutilized Funds

The Board has proposed to utilize the unutilized ₹115 lakh (originally for issue expenses) towards working capital requirements, subject to shareholders' approval. A postal ballot notice dated September 09, 2026 was issued for remote e-voting scheduled to conclude on October 11, 2026. As of September 30, 2026, the voting process was ongoing.

There has been no deviation/variation in the use of public issue proceeds for the period ended September 30, 2026.

Related Party Transactions

Half Year Ended September 30, 2026

Total value of transactions: ₹310.85 lakh

Key transactions include:

  • Purchases from Shreeshyam Agro Proteins Private Limited: ₹3.88 lakh
  • Rent paid to Shreeshyam Agro Proteins Private Limited: ₹0.9 lakh
  • Purchases from Daga Brothers: ₹219.02 lakh
  • Sales to Shreeshyam Agro Proteins Private Limited: ₹20.68 lakh
  • Sales to Daga Brothers: ₹38.63 lakh
  • Sales to Neetu Daga (Relative of Director): ₹0.01 lakh
  • Sales to Seema Daga (Relative of Director): ₹0.01 lakh
  • Director Sitting Fees: ₹0.40 lakh total
  • Remuneration to Key Management Personnel:
  • Deepak Pal Daga (Managing Director): ₹15.00 lakh
  • Vimal Kumar Daga (Whole Time Director): ₹9.00 lakh
  • Ratan Lal Bareth (CFO): ₹1.52 lakh
  • Khushbu Sethi (Company Secretary): ₹1.80 lakh

All transactions were approved by the Audit Committee.

Certifications

  • CEO & CFO certification provided by Deepak Pal Daga (Managing Director) and Ratan Lal Bareth (CFO) confirming the financial results don't contain false/misleading statements
  • Limited review report by Deepak Agal & Co, Chartered Accountants (Firm Registration No. 019684C) stating nothing has come to their attention suggesting material misstatement